BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33482195)

  • 21. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
    Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiopoietin-like 3 in lipoprotein metabolism.
    Kersten S
    Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
    Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S
    J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
    Fowler A; Sampson M; Remaley AT; Chackerian B
    Vaccine; 2021 Sep; 39(40):5780-5786. PubMed ID: 34474934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
    Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
    J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
    Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
    Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of lipoprotein lipase-mediated lipolysis of triglycerides.
    Basu D; Goldberg IJ
    Curr Opin Lipidol; 2020 Jun; 31(3):154-160. PubMed ID: 32332431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intrinsic instability of the hydrolase domain of lipoprotein lipase facilitates its inactivation by ANGPTL4-catalyzed unfolding.
    Leth-Espensen KZ; Kristensen KK; Kumari A; Winther AL; Young SG; Jørgensen TJD; Ploug M
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
    Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
    J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1.
    Lichtenstein L; Kersten S
    Biochim Biophys Acta; 2010 Apr; 1801(4):415-20. PubMed ID: 20056168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8.
    Sylvers-Davie KL; Davies BSJ
    Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E493-E508. PubMed ID: 34338039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity.
    Chen YQ; Zhen EY; Russell AM; Ehsani M; Siegel RW; Qian Y; Konrad RJ
    J Lipid Res; 2023 Oct; 64(10):100441. PubMed ID: 37666362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A unified model for regulating lipoprotein lipase activity.
    Zhang R; Zhang K
    Trends Endocrinol Metab; 2024 Jun; 35(6):490-504. PubMed ID: 38521668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unfolding of monomeric lipoprotein lipase by ANGPTL4: Insight into the regulation of plasma triglyceride metabolism.
    Kristensen KK; Leth-Espensen KZ; Mertens HDT; Birrane G; Meiyappan M; Olivecrona G; Jørgensen TJD; Young SG; Ploug M
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4337-4346. PubMed ID: 32034094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism.
    Kersten S
    J Lipid Res; 2021; 62():100150. PubMed ID: 34801488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
    DiDonna NM; Chen YQ; Konrad RJ
    Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
    Kersten S
    Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of angiopoietin-like proteins 3 and 4 to hemodialysis.
    Mahmood D; Makoveichuk E; Nilsson S; Olivecrona G; Stegmayr B
    Int J Artif Organs; 2014 Jan; 37(1):13-20. PubMed ID: 24634330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
    Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
    J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
    Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
    J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.